Back to DNLI
KBC Group NV DNLI Position History
Denali Therapeutics Inc. • Healthcare
Quarters held
5
Latest value
$102K
Q3 2026
Peak value
$127K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $65K |
| Q4 2025 | $103K |
| Q1 2026 | $95K |
| Q2 2026 | $127K |
| Q3 2026 | $102K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $102K | 4.9K | — | — |
| Q2 2026 | $127K | 4.9K | — | — |
| Q1 2026 | $95K | 4.9K | — | — |
| Q4 2025 | $103K | 6.3K | — | — |
| Q3 2025 | $65K | 4.5K | — | — |
Other funds holding DNLI
$831.4M
$723.7M
$653.8M
$619.1M
$610.5M
$561.5M
$528.6M